Wave Life Sciences Hits Day High with 8.83% Surge in Stock Price
Wave Life Sciences has seen a notable increase in stock performance recently, with a significant rise on October 29, 2025. However, the company faces longer-term challenges, including a substantial decline over the past year and negative operating cash flow, reflecting the volatility in the biotechnology sector.
Wave Life Sciences has experienced a significant uptick in its stock performance, gaining 8.83% on October 29, 2025. The stock reached an intraday high of USD 9.75, reflecting a notable moment in its trading activity. Over the past week, Wave Life Sciences has shown a robust performance with a 15.04% increase, outpacing the S&P 500, which rose by 2.31% during the same period. Despite these short-term gains, the company has faced challenges in its longer-term performance metrics. Over the past year, Wave Life Sciences has seen a decline of 44.19%, contrasting sharply with the S&P 500's growth of 18.33%. The company's market capitalization stands at USD 1,206 million, categorizing it as a small-cap entity within the Pharmaceuticals and Biotechnology industry.
Key financial indicators reveal a complex picture, with negative operating cash flow and a significant drop in net sales. The stock's price-to-book ratio is 8.20, and it currently does not offer a dividend yield. As Wave Life Sciences navigates these dynamics, its recent performance highlights the volatility often seen in the biotechnology sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
